These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 34285854)

  • 1. Propensity Score Matching Analysis of the Effect of Payer Status on the Survival of Colon Cancer Patients.
    Shi L; Suh W; Kavanaugh MM; Mills G; Thayer S; Shi R
    Cureus; 2021 Jun; 13(6):e15748. PubMed ID: 34285854
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Effect of Payer Status on Survival of Patients with Stage I/II Non-small Cell Lung Cancer: NCDB 1998-2011.
    Shi R; Diaz R; Shi Z; Duvall E; Mills G
    Anticancer Res; 2016 Jan; 36(1):319-26. PubMed ID: 26722060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Effect of Payer Status on Survival of Patients With Prostate Cancer.
    Suh W; Master S; Liu L; Mills G; Shi R
    Cureus; 2021 Feb; 13(2):e13329. PubMed ID: 33738172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insurance Status and Other Non-biological Factors Predict Outcomes in Acute Myelogenous Leukemia: Analysis of Data from the National Cancer Database.
    Master S; Munker R; Shi Z; Mills G; Shi R
    Anticancer Res; 2016 Sep; 36(9):4915-21. PubMed ID: 27630349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association Between Primary Payer Status and Survival in Patients With Stage III Colon Cancer: An National Cancer Database Analysis.
    Ahmed A; Tahseen A; England E; Wolfe K; Simhachalam M; Homan T; Sitenga J; Walters RW; Silberstein PT
    Clin Colorectal Cancer; 2019 Mar; 18(1):e1-e7. PubMed ID: 30297265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of payer status on breast cancer survival: a retrospective study.
    Shi R; Taylor H; McLarty J; Liu L; Mills G; Burton G
    BMC Cancer; 2015 Apr; 15():211. PubMed ID: 25884399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is Medicaid Expansion Associated with Improved Nonmetastatic Colon Cancer Survival? An Analysis of the National Cancer Database.
    Reitz ACW; Switchenko JM; Gillespie TW
    Am Surg; 2023 May; 89(5):1764-1773. PubMed ID: 35213813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In-Hospital Management and Outcomes After ST-Segment-Elevation Myocardial Infarction in Medicaid Beneficiaries Compared With Privately Insured Individuals.
    Patel N; Gupta A; Doshi R; Kalra R; Bajaj NS; Arora G; Arora P
    Circ Cardiovasc Qual Outcomes; 2019 Jan; 12(1):e004971. PubMed ID: 30606054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The association of health insurance with the survival of cancer patients with brain metastases at diagnosis.
    Kolomaya A; Amin S; Lin C
    Tech Innov Patient Support Radiat Oncol; 2021 Dec; 20():46-53. PubMed ID: 34926840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of health insurance status with presentation, treatment and outcomes in soft tissue sarcoma.
    Jain V; Venigalla S; Sebro RA; Karakousis GC; Wilson RJ; Weber KL; Shabason JE
    Cancer Med; 2019 Oct; 8(14):6295-6304. PubMed ID: 31483578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of payer status on survival in parotid malignancy.
    Stubbs VC; Rajasekaran K; Chen J; Cannady SB; Brant JA; Newman JG
    Am J Otolaryngol; 2019; 40(4):555-559. PubMed ID: 31097206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of insurance status and ethnicity with cancer stage at diagnosis for 12 cancer sites: a retrospective analysis.
    Halpern MT; Ward EM; Pavluck AL; Schrag NM; Bian J; Chen AY
    Lancet Oncol; 2008 Mar; 9(3):222-31. PubMed ID: 18282806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does payer status impact clinical outcomes after cardiac surgery? A propensity analysis.
    Polanco A; Breglio AM; Itagaki S; Goldstone AB; Chikwe J
    Heart Surg Forum; 2012 Oct; 15(5):E262-7. PubMed ID: 23092662
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insurance Payer Type Affects Outcomes after Revision Total Joint Arthroplasty: A Matched Cohort Analysis.
    Tirumala V; Klemt C; Esposito JG; Robinson MG; Barghi A; Kwon YM
    Arch Bone Jt Surg; 2022 Apr; 10(4):328-338. PubMed ID: 35721591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medicaid insurance as primary payer predicts increased mortality after total hip replacement in the state inpatient databases of California, Florida and New York.
    Xu HF; White RS; Sastow DL; Andreae MH; Gaber-Baylis LK; Turnbull ZA
    J Clin Anesth; 2017 Dec; 43():24-32. PubMed ID: 28972923
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of insurance status with survival in patients with cutaneous T-cell lymphoma.
    Tang R; Su C; Bai HX; Zeng Z; Karakousis G; Zhang PJ; Zhang G; Xiao R
    Leuk Lymphoma; 2019 May; 60(5):1253-1260. PubMed ID: 30326769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medicaid Payer Status Is Associated with Increased 90-Day Morbidity and Resource Utilization Following Primary Total Hip Arthroplasty: A Propensity-Score-Matched Analysis.
    Shau D; Shenvi N; Easley K; Smith M; Bradbury T; Guild G
    J Bone Joint Surg Am; 2018 Dec; 100(23):2041-2049. PubMed ID: 30516627
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Applied comparison of large-scale propensity score matching and cardinality matching for causal inference in observational research.
    Fortin SP; Johnston SS; Schuemie MJ
    BMC Med Res Methodol; 2021 May; 21(1):109. PubMed ID: 34030640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in insurance status and emergency department visits after the 2008 economic downturn.
    Watts SH; David Bryan E; Tarwater PM
    Acad Emerg Med; 2015 Jan; 22(1):73-80. PubMed ID: 25545581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Effect of Long-Term Traditional Chinese Medicine Treatment on Survival Time of Colorectal Cancer Based on propensity Score Matching: A Retrospective Cohort Study.
    Wang Y; Liu P; Fang Y; Tian J; Li S; Xu J; Zhao F; Yin X; Zhang Q; Li Y
    Evid Based Complement Alternat Med; 2020; 2020():7023420. PubMed ID: 32089727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.